Medical technology startup Sense Neuro Diagnostics has received $250,000 in funding from St. Elizabeth Healthcare in Edgewood, Kentucky. The investment will help Sense Neuro Diagnostics as the company advances clinical trials in its effort to commercialize a non-invasive technology to monitor traumatic brain injuries.

Sense Neuro Diagnostics is getting ready to participate in the Arizona Commerce Authority Venture Ready Accelerator, an initiative that helps startups refine business plans, improve go-to-market execution strategies, and increase investor readiness.

Cincinnati-based Sense Neuro Diagnostics is pursuing new international investment opportunities after coming in second place in the Unicorn CUP Finals startup competition. The pitch event is affiliated with Unicorn Events, the world’s largest startup pitch competition that focuses on discovering extraordinary startups that have the potential to achieve a valuation of $1 billion or more.

Sense Diagnostics was recently recognized as one of seven winners of the 2022 Medical Innovation Challenge at the Defense TechConnect (DTC) Innovation Summit & Expo, the nation’s largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements.